A while back I wrote about how the lead researcher at the Whittemore Peterson Institute, Judy Mikovits, is speaking at Autismone, a huge anti-vax rally in Chicago later this month.
I thought Judy was just a crank. Dime a dozen, whatevs.
Turns out things are worse than that.
Much much worse than that.
Its cranks all the way down.
Vincent Lombardi, first author on the original ‘XMRV causes Chronic Fatigue’ Science paper, founded some weird testing company several years back. This weird testing company was then bought by Harvey Whittemore (father of The Princess That Cant Be Named), and turned into VIP Dx.
VIP Dx is now the only company that has WPIs SUPER EXTRA SPECIAL XMRV test (dont have super special test, cant see XMRV!).
The Vice President of VIP Dx is… Judy Mikovits.
So lets be honest, here, VIP Dx is apparently the for profit arm of WPI. The same individuals are involved in both groups.
Well, turns out VIP Dx is buddy-buddy with BioRay. At BioRay, you can buy all kinds of fantastic supplements, like a mouthwash that keeps your dental fillings from giving you mercury poisoning, and my long-time favorite supplement, colloidal silver.
Apparently, VIP Dx and BioRay have teamed up to ‘cure’ autistic kids by pouring this crap down their throats:
BioRay and VIP Dx Labs present collaborative CytoFlora study results at Autism OneVIP Dx Laboratory is highly regarded in the field of Chronic Fatigue Syndrome and neuro immune disease testing. VIP Dx also tests for intestinal gut dysbiosis by means of the Immunobilan test, the same test used in BioRay’s CytoFlora study. The CytoFlora study showed remarkable results with autistic children. Specifically:
* Improvement in speech and social interaction
* Reduction in abdominal pain and gastro-intestinal symptomsUntil now, antibiotics have been the only recognized treatment for elevated pathogenic bacteria and gastrointestinal inflammation. “We test many Chronic Fatigue patients in our laboratory with elevated IgA and IgM to bacterial antigens and most are put on antibiotics for six to eight months followed by a course of probiotics,” noted Craig Setter of VIP Dx Laboratory. “The CytoFlora results represent the first time I have seen such a significant decrease in IgA and IgM in only a few weeks.”
BioRay will be presenting the results and methodology of the CytoFlora study at Autism One.
Eleven children from BioRay’s Cytoflora study were also tested for XMRV at VIP Dx Labs. Six tested positive for the gammaretrovirus XMRV. Two of these children are siblings whose mother also tested positive for XMRV. Dr. Judy Mikovits, Director of Research at Whittemore Peterson Institute, will be speaking about XMRV at Autism One. We believe this unique and informative presentation will be of interest to doctors and parents in the world of Autism.
VIP Dx licensed the technology for testing XMRV from Whittemore Peterson Institute. Come and speak with Marguerite Ross, Director of Marketing & Client Relations at VIP Dx, and Dr. Vincent Lombardi, PhD, Researcher & Consultant to VIP Dx. The VIP Dx booth is located next to the BioRay booth outside the main auditorium. This is a special opportunity to hear more about testing and on-going research occurring in the world of neuro-immune diseases.
Note the glowing review of this ‘supplement’ from VIP Dx.
And wait for it– Judy can ‘find’ XMRV in autistic kids!
The findings have potential significance for a number of other disorders including, it turns out, autism.Researchers tested blood samples from a “small group of children” with autism and found that 40% of them were positive for XMRV, according to a statement from the Nevada Commission on Autism Spectrum Disorders. More testing is underway which, the Commission said, “could dramatically increase that 40% positive finding.” (Given the small sample size, such a statement is purely speculative).
Now, VIP Dx, BioRay, and Judy Mikovits are all going to AutismOne, with VIP Dx and BioRay having booths there to peddle their respective crap.
Amazing all the coincidences that are lining up here– WPI just happened to find a retrovirus thats associated with every and any disease under the sun, including autism. But no one can find this virus unless they use tests from VIP Dx, a company who happens to be partnering up with BioRay, to sell anti-autism supplements.
Meanwhile, Judy has also ‘found’ XMRV in patients with Chronic Lyme Disease:
Q: How might the finding of the XMRV virus relate to Lyme Disease?A: We are seeing XMRV in Chronic Lyme patients sent to us from several physicians. The hypothesis that chronic XMRV infection creates an underlying immune deficiency is consistent with many co-pathogens including Lyme.
Lo and behold, look at what other tests VIP Dx offers: LYME DISEASE!
Minor problem. *wispers loudly* Chronic lyme disease, under no uncertain terms, does not exist.
*slow clap*
Touche to you, troupe of mean hearted snake-oil salesmen! Duped Science. Duped the National Cancer Institute. Duped Cleveland Clinic. Even got Judy to completely and utterly sell out her mentor.
Someone has requested my opinion on these two letters in Science. I 100% believe the Netherlands groups recollection of Judys presentation at the Lisbon conference. Not only would disbelieving them require mass hallucination as an explanation, and them flat out lying about questions they asked her in the post-talk Q&A, but I have listened/watched/read numerous presentations given by Judy Mikovits. Her manner of speaking is very imprecise, and sometimes she says that are completely wrong (I dont believe I have ever seen her use the word ‘quasispecies’ appropriately. She also said some very bizarre things about endogenous retroviruses.).
Then on the other hand, we have one description of the patient cohort in the original Science paper:
Patient samples. Banked samples were selected for this study from patients fulfilling the 1994 CDC Fukuda Criteria for Chronic Fatigue Syndrome (S1) and the 2003 Canadian Consensus Criteria for Chronic Fatigue Syndrome/myalgic encephalomyelitis (CFS/ME) and presenting with severe disability. Samples were selected from several regions of the United States where outbreaks of CFS had been documented (S2). These are patients that have been seen in private medical practices, and their diagnosis of CFS is based upon prolonged disabling fatigue and the presence of cognitive deficits and reproducible immunological abnormalities. These included but were not limited to perturbations of the 2-5A synthetase/RNase L antiviral pathway, low natural killer cell cytotoxicity (as measured by standard diagnostic assays), and elevated cytokines particularly interleukin-6 and interleukin-8. In addition to these immunological abnormalities, the patients characteristically demonstrated impaired exercise performance with extremely low VO2 max measured on stress testing. The patients had been seen over a prolonged period of time and multiple longitudinal observations of the clinical and laboratory abnormalities had been documented.
One description Judy was giving at conferences:
Moreover, it was surprising to learn during the presentation of this study at the 2009 Tri-Society Annual Conference in Lisbon (3) that the material studied was derived from patients from the well-publicized “outbreak” of CFS from Incline Village, Nevada, dating back to the 1980s. This outbreak has long been suggested to be caused by a viral infection, most notably with Epstein-Barr virus (4) or human herpes virus 6 (5)…
…Mikovits also reported a cytokine profile with high interleukin-8 and macrophage inflammatory protein-1{alpha} and a low interferon-{alpha} concentration (3). The authors suggested that the selection of their group of CFS patients was partly based on reproducible immunological abnormalities and presented it as an additional argument for the viral etiology of CFS. Although this cytokine profile may be associated with a possible viral infection (while by no means being necessarily specific), it has not been reported previously as such in patients with CFS.
And now a third description of that same cohort in a letter in Science:
Samples included in our study (1) were from CFS patients who fulfilled both the Fukuda criteria and the Canadian Consensus Criteria (CCC), regardless of severity. We regret that a sentence in the original supporting online material in (1) implied that immunological abnormalities were part of the CFS diagnosis; indeed, while many such patients do exhibit such abnormalities (5, 6), they were not required for diagnosis. All patients that met Centers for Disease Control and Prevention and CCC criteria were accepted; none were excluded. Patient samples were obtained from 2006 to 2009 and stored in the Whittemore Peterson Institute (WPI) repository. We did not state in Lisbon (7) or elsewhere that the samples analyzed in (1) were only from patients from documented outbreaks of CFS, nor did we state that the 101 patients described in (1) exhibited all the immunological abnormalities described in our Lisbon conference presentation.
LOL, WUT??? And its everyone elses fault that there is any confusion?? Just like its everyone elses fault they didnt understand WPIs PCR methods. Cause PCR is soooooo hard, no other lab on the planet can be trusted to do it without Judy personally ‘instructing’ them.
Recently the American scientist Dr. Judy Mikovits visited several European research groups to instruct them in the proper laboratory technique.
Bull shit.
Bull fucking shit.